DocTalk Tweet Chat "Drug Shortages in the US" Scheduled for July 17


A trio of emergency medicine experts headline our first entry in the weekly healthcare conversation on Twitter.

How are drug shortages affecting your practice, your patients, your colleagues, and your field?

In the first ever #DocTalk Tweet Chat, a team of experts with the American College of Emergency Physicians will join MD Magazine® to discuss the "State of Drug Shortages in the US."

#DocTalk is a weekly conversation featured on Twitter that focuses on the biggest issues in healthcare today.

Join us Wednesday, July 17, 1:30 PM EST for the start of our chat, to be led by:

  • Howard Mell, MD, MPH, CEP, FACEP (@DrHowieMell)
  • Jordan M. Warchol, MD, MPH (@ActuallyDrJ)
  • Angela Gardner, MD, FACEP (@ACEPHeadliner)

The team of experts will lead discussion on the following questions and topics:

  • Where do drug shortages register on your list of concerns for your practice?
  • A 2018 study showed more than half of all drug shortages occurred for “unknown” reasons. How well do you understand the drivers of increased drug shortages in the last decade?
  • Have you in your practice ever had to work around a drug shortage? What drug was it? How did it affect the care of patients?
  • How equipped is your field of care to work around any potential shortages? What concerns do you still have?
  • What role do physicians play in pursuing improved legislation that would limit/reduce the rate of drug shortages in the US?

We invite all interested Twitter users to participate in the chat and contribute their own perspective and questions.

Be sure to search for “#DocTalk,” follow MD Mag on Twitter (@MDMagazine), and look for the social media icon signifying the chat:

DocTalk tweet chat doctors

If you’re a frequent Twitter user with a background in healthcare and interest in leading a #DocTalk chat with your colleagues, feel free to reach out to us here.

Related Videos
Elizabeth Cerceo, MD | Credit: ACP
© 2024 MJH Life Sciences

All rights reserved.